Reversible disruption of XPO1-mediated nuclear export inhibits respiratory syncytial virus (RSV) replication

Reversible disruption of XPO1-mediated nuclear export inhibits respiratory syncytial virus (RSV) replication

Abstract Respiratory syncytial virus (RSV) is the primary cause of serious lower respiratory tract disease in infants, young children, the elderly and immunocompromised individuals. Therapy for RSV infections is limited to high risk infants and there are no safe and efficacious vaccines. Matrix (M)...

Full description

Bibliographic Details
Main Authors:	Cynthia Mathew, Sharon Tamir, Ralph A. Tripp, Reena Ghildyal
Format:	Article
Language:	English
Published:	Nature Portfolio 2021-09-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-021-98767-2

Similar Items

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
by: Jackelyn Murray, et al.
Published: (2022-04-01)

Pathobiology of Respiratory Syncytial Virus (RSV)
by: Ralph A. Tripp, et al.
Published: (2020-07-01)

Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication
by: Ralph A. Tripp, et al.
Published: (2022-03-01)

Effect of Exportin 1/XPO1 Nuclear Export Pathway Inhibition on Coronavirus Replication
by: Masmudur M. Rahman, et al.
Published: (2025-02-01)

RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein
by: Harrison C. Bergeron, et al.
Published: (2022-10-01)

XPO1-dependent nuclear export as a target for cancer therapy
by: Nancy G. Azizian, et al.
Published: (2020-06-01)

Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
by: Harrison C. Bergeron, et al.
Published: (2023-04-01)

Monoterpene-Containing Substituted Coumarins as Inhibitors of Respiratory Syncytial Virus (RSV) Replication
by: Tatyana M. Khomenko, et al.
Published: (2021-12-01)

Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine Types
by: Lydia J. Atherton, et al.
Published: (2019-10-01)

Nuclear Export in Non-Hodgkin Lymphoma and Implications for Targeted XPO1 Inhibitors
by: Kyla L. Trkulja, et al.
Published: (2023-01-01)

Combination therapy using monoclonal antibodies against respiratory syncytial virus (RSV) G glycoprotein protects from RSV disease in BALB/c mice.
by: Hayat Caidi, et al.
Published: (2012-01-01)

Respiratory Syncytial Virus (RSV) Update
by: Leonard R. Krilov, et al.
Published: (2022-09-01)

New Inhibitors of Respiratory Syncytial Virus (RSV) Replication Based on Monoterpene-Substituted Arylcoumarins
by: Tatyana M. Khomenko, et al.
Published: (2023-03-01)

Inhibition of XPO-1 Mediated Nuclear Export through the Michael-Acceptor Character of Chalcones
by: Marta Gargantilla, et al.
Published: (2021-11-01)

Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice.
by: Gertrud U Rey, et al.
Published: (2013-01-01)

The Development of Animal Models for Respiratory Syncytial Virus (RSV) Infection and Enhanced RSV Disease
by: Gengxin Zhang, et al.
Published: (2024-10-01)

Interaction Between the Matrix Protein and the Polymerase Complex of Respiratory Syncytial Virus
by: Elliot B. Atchison, et al.
Published: (2024-12-01)

Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity
by: Diego R. Hijano, et al.
Published: (2019-03-01)

The nuclear export receptor OsXPO1 is required for rice development and involved in abiotic stress responses
by: Qiufei Peng, et al.
Published: (2023-02-01)

XPO1 inhibition with selinexor synergizes with proteasome inhibition in neuroblastoma by targeting nuclear export of IkB
by: Basia Galinski, et al.
Published: (2021-08-01)

Modeling household dynamics on Respiratory Syncytial Virus (RSV)
by: Mahikul, W, et al.
Published: (2019)

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
by: Dvir Gatt, et al.
Published: (2023-01-01)

Modeling household dynamics on Respiratory Syncytial Virus (RSV).
by: Wiriya Mahikul, et al.
Published: (2019-01-01)

The eukaryotic elongation factor 1A is critical for genome replication of the paramyxovirus respiratory syncytial virus.
by: Ting Wei, et al.
Published: (2014-01-01)

Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185.
by: Yoko Tabe, et al.
Published: (2015-01-01)

Effects of formalin-inactivated respiratory syncytial virus (FI-RSV) in the perinatal lamb model of RSV.
by: Rachel J Derscheid, et al.
Published: (2013-01-01)

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
by: Anne M Hause, et al.
Published: (2017-01-01)

Respiratory Syncytial Virus Matrix (M) Protein Interacts with Actin In Vitro and in Cell Culture
by: Shadi Shahriari, et al.
Published: (2018-09-01)

Structural Insights into How Yrb2p Accelerates the Assembly of the Xpo1p Nuclear Export Complex
by: Masako Koyama, et al.
Published: (2014-11-01)

Immunopathology of RSV: An Updated Review
by: Harrison C. Bergeron, et al.
Published: (2021-12-01)

Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel.
by: Shira Hirsh, et al.
Published: (2014-01-01)

Polymyalgia rheumatica following respiratory syncytial virus (RSV) vaccination
by: Mohamad El Labban, et al.
Published: (2024-06-01)

Perinatal Lamb Model of Respiratory Syncytial Virus (RSV) Infection
by: Mark R. Ackermann, et al.
Published: (2012-10-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
by: Selir M. Straliotto, et al.
Published: (1994-03-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
by: Selir M. Straliotto, et al.
Published: (1994-03-01)

Correction: Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
by: Anne M Hause, et al.
Published: (2017-01-01)

The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection
by: Abhijeet A. Bakre, et al.
Published: (2017-07-01)

Respiratory syncytial virus (RSV) attachment and nonstructural proteins modify the type I interferon response associated with suppressor of cytokine signaling (SOCS) proteins and IFN-stimulated gene-15 (ISG15)
by: Tripp Ralph A, et al.
Published: (2008-10-01)

Antibody gene transfer for prophylaxis of respiratory syncytial virus (RSV) infection
by: Antepowicz, A, et al.
Published: (2018)

Effects of palivizumab prophylaxis on respiratory syncytial virus (RSV) infections in Montenegro
by: Envera Lekic, et al.
Published: (2024-05-01)